AAO-HNS GUIDELINES Bundle (free trial)

Allergic Rhinitis

American Academy of Otolaryngology-Head and Neck Surgery Foundation GUIDELINES Apps brought to you free pf charge, courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/453532

Contents of this Issue

Navigation

Page 12 of 13

11 Recommendations for Symptom Frequency Recommendations for Symptom Severity Patient Preference Intermittent Persistent Mild Severe ++ ++ ++ ++ High ++ + + No High ++ + b ++ + High No Yes Yes Not as monotherapy Low Table 10. Comparison of Features of SCIT and SLIT (cont'd) SCIT SLIT FDA status FDA approved • SLIT aqueous FDA "off-label" use • SLIT tablets approved by FDA in April 2014; limited number of allergens available for treatment Socioeconomic • CPT code exists for SCIT vial preparation and injections • Covered by most insurance plans • No CPT code exists for SLIT aqueous preparation • SLIT aqueous not covered by most insurance plans • SLIT tablet insurance coverage to be determined by individual insurance carriers

Articles in this issue

Archives of this issue

view archives of AAO-HNS GUIDELINES Bundle (free trial) - Allergic Rhinitis